Navigation Links
American Oriental Bioengineering Announces September Investor Conferences Participation
Date:9/8/2009

representative.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.


'/>"/>
SOURCE American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device
2. American Oriental Bioengineerings Jinji Capsules and Boke Nasal Spray Designated Among Chinas Top Branded Drugs of 2009
3. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
4. American Oriental Bioengineering Announces Change in Independent Auditor
5. What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate
6. American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
7. American Oriental Bioengineering to Report Second Quarter 2009 Financial Results on August 7, 2009
8. American Oriental Bioengineering Honorably Elected a Top 20 Most Competitive Public Pharmaceutical Company in China
9. American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals
10. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
11. New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... 10 December 2009 -- Researchers have discovered a new explanation ... The more excess copies of a certain gene, the more ... X-chromosome; and it is suspected that it is the amount ... results are being published in the American Journal of ... the group of Guy Froyen connected to VIB, a life ...
(Date:12/11/2009)... Ambit Biosciences Corporation announced today the enrollment and dosing ... Center of the first patient in the ACE ( ... fficacy) Phase 2 pivotal trial in patients with relapsed ... a novel, orally available, potent and highly selective small ... kinase-3 (FLT3) inhibitor. The ACE study is designed ...
(Date:12/11/2009)... Dec. 11 Marrone Bio Innovations (MBI) ... management team. Mr. Chris Hildreth joined MBI as ... responsible for expanding all commercial aspects of the ... Dr. Kin Sing (Ray) Lam joined MBI as ... company,s development efforts in scaling its broad pipeline ...
(Date:12/11/2009)... Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, ... announced the appointment of Dr. Alan Warrander to ... and Business Development. ,, "Dr. Warrander will be ... strategy for REOLYSIN(R)," said Dr. Brad Thompson, President ... on the design of a Phase 3 trial ...
Breaking Biology Technology:Amount of gene surplus determines severity of mental retardation in males 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3
... Oct. 22 Transgenomic Inc. (OTC,Bulletin Board: TBIO) announces the following Webcast:, ... Conference Call, ... Eastern, Where: http://www.transgenomic.com/events.asp?id=6 , How: ... web at the ...
... Oct. 22 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: ... and commercializing novel anti-infective products, today,announced that ... to lead its field force hiring effort ... tablets, 775mg) launch. The,launch is targeted for ...
... Calif., Oct. 22 Genoptix, Inc.,(Nasdaq: GXDX ... Company,s participation at the BIOCOM Investor Conference 2008,scheduled ... La Jolla, CA on October,26-28, 2008., Dr. ... present at the,conference on Monday, October 27, beginning ...
Other Biology Technology:Webcast Alert: Transgenomic Inc. Announces Third Quarter 2008 Earnings Release Conference Call Webcast 2MiddleBrook Hires TalenTactics to Recruit National Field Force 2MiddleBrook Hires TalenTactics to Recruit National Field Force 3Genoptix Announces Participation at the BIOCOM Investor Conference 2008 2
(Date:12/14/2009)... Rice University and Baylor College of Medicine (BCM) have ... real time with MRI as it homes in on ... kills them with heat. The all-in-one particle is one ... "theranostics" that develops technologies physicians can use to diagnose ... research is available online in the journal Advanced ...
(Date:12/14/2009)... study to date of the proteins in a species ... clues to how similar regeneration could be induced in ... at Indiana University-Purdue University Indianapolis and colleagues investigated over ... a type of salamander that has the unique natural ... with the hope that this knowledge will contribute to ...
(Date:12/14/2009)... Dec. 14 MODA Technology Partners, a ... utility and product testing for the Pharmaceutical industry, ... the company,s third generation mobile data acquisition platform. ... to further automate their regulated manufacturing processes. ... ,, Fully-Configurable Test Methods: Each ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Kidney Injury While Hospitalized May Lead to Future Dialysis 57273 1Kidney Injury While Hospitalized May Lead to Future Dialysis 57273 2Diabetes Medications Dont Lower Inflammation 57271 1Diabetes Medications Dont Lower Inflammation 57271 2Diabetes Medications Dont Lower Inflammation 57271 3Blacks Fare Worse After Cardiac Arrest 57269 1Blacks Fare Worse After Cardiac Arrest 57269 2Blacks Fare Worse After Cardiac Arrest 57269 3
... The first comprehensive reconstruction of an extreme warm period ... in carbon dioxide (CO 2 ) levels as well ... from equatorial regions, and greenhouse gases on Earth,s temperature. ... predictions of future climate and improved understanding of today,s ...
... the challenge of global food security featuring prominently in ... such that the term "food security" has now become ... is launching the scientific journal Food Security: The ... to Food with the first issue appearing in ...
... Despite broad "dolphin safe" practices, fishing activities have continued ... Ocean dolphin population, a new report led by a ... Diego has concluded. , Populations of dolphins in the ... successful regulations and agreements were enacted to reduce dolphin ...
Other Biology News:Getting warmer? Prehistoric climate can help forecast future changes 2Springer launches Food Security 2Dolphin population stunted by fishing activities, Scripps/NOAA study finds 2Dolphin population stunted by fishing activities, Scripps/NOAA study finds 3
... Rabbit polyclonal to Endothelin B ... Type B Receptor-Like Protein 2 (ETBR-LP-2) ... ESTs have been isolated from human ... Immunogen: Synthetic peptide (unfortunately, the ...
Mouse monoclonal [164-12-2] to Ampicillin ( Abpromise for all tested applications)....
... product contains 5 ml Dynabeads Epoxy (4.5 ... ether (epoxy) reactive groups. Ideal for coupling ... absorbed hydrophobically on initial coupling with covalent ... and sulphydryll groups (SH)) occurring within ...
... Normal;heading 1;heading 2;Many ... and experimental situations ... standard transfection and ... systems. ViraPower Lentiviral ...
Biology Products: